Spyre Therapeutics (SYRE) Return on Capital Employed Growth (1y) (2017 - 2026)
Spyre Therapeutics (SYRE) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,457.00 |
| 10 | Spyre Therapeutics | 259.59 Mn | 259.59 Mn | - | 1,194.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,194.00 |
| Dec 31, 2025 | 929.00 |
| Sep 30, 2025 | 714.00 |
| Jun 30, 2025 | -950.00 |
| Mar 31, 2025 | 3,159.00 |
| Dec 31, 2024 | 5,462.00 |
| Sep 30, 2024 | 6,733.00 |
| Jun 30, 2024 | -29,188.00 |
| Mar 31, 2024 | 8,805.00 |
| Dec 31, 2023 | 2,723.00 |
| Sep 30, 2023 | -1,375.00 |
| Jun 30, 2023 | 36,714.00 |
| Mar 31, 2023 | -7,142.00 |
| Dec 31, 2022 | -6,103.00 |
| Sep 30, 2022 | -4,784.00 |
| Jun 30, 2022 | -6,192.00 |
| Mar 31, 2022 | -2,764.00 |
| Dec 31, 2021 | -877.00 |
| Sep 30, 2021 | -404.00 |
| Jun 30, 2021 | 3,335.00 |